TTY Biopharm Company Limited logo

TTY Biopharm Company Limited (4105)

Market Closed
10 Aug, 05:30
TWSE TWSE
NT$
77. 20
+0.7
+0.915%
NT$
18.67B Market Cap
- P/E Ratio
14% Div Yield
496,310 Volume
- Eps
NT$ 76.5
Previous Close
Add Transaction
Day Range
76.3 77.4
Year Range
71.6 87
Want to track 4105 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4105 closed yesterday higher at NT$77.2, an increase of 0.915% from Friday's close, completing a monthly increase of 1.9815% or NT$1.5. Over the past 12 months, 4105 stock lost -5.7387%.
4105 pays dividends to its shareholders, with the most recent payment made on Apr 27, 2026. The next estimated payment will be in In 8 months on Apr 27, 2027 for a total of NT$4.5.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.5733%, based on the last three reports.
TTY Biopharm Company Limited has completed 9 stock splits, with the recent split occurring on Aug 13, 2014.
The company's stock is traded on one exchange.

4105 Chart

People also search for

Far Eastern New Century Corporation
NT$ 27.3
+0.1835%
Feng Tay Enterprise Co., Ltd.
NT$ 71.3
+1.567%
Eclat Textile Company Ltd.
NT$ 332
-1.4837%
Nien Made Enterprise Co., Ltd.
NT$ 398
+5.0132%
PharmaEssentia Corp.
NT$ 1,460
+9.7744%

TTY Biopharm Company Limited (4105) FAQ

What is the stock price today?

The current price is NT$77.20.

On which exchange is it traded?

TTY Biopharm Company Limited is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4105.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 14%.

What is its market cap?

As of today, the market cap is 18.67B.

Has TTY Biopharm Company Limited ever had a stock split?

TTY Biopharm Company Limited had 9 splits and the recent split was on Aug 13, 2014.

TTY Biopharm Company Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
TWSE Exchange
TW0004105002 ISIN
Taiwan Country
- Employees
26 Mar 2026 Last Dividend
13 Aug 2014 Last Split
- IPO Date

Overview

TTY Biopharm Company Limited is a versatile entity engaged in the development, production, and international distribution of pharmaceutical and chemical drugs. Established in 1960 and based in Taipei, Taiwan, the company has broadened its reach globally through a strategic amalgamation of subsidiaries. It navigates the pharmaceutical industry through various specialized units: Oncology Business Unit, Health Care Unit, Anti-infection Business Unit, Domestic Cardiovascular and Gastrointestinal Drugs Business Unit, China Medicine Business Unit, and Other segments. Besides its primary focus on pharmaceuticals, TTY Biopharm also ventures into functional foods, alongside import, export trading, and investment activities, thereby encapsulating a comprehensive approach to health and wellness.

Products and Services

  • Oncology Drugs: TTY Biopharm offers a wide array of oncology drugs including Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre. These products are targeted for anti-cancer treatments and supplementary care.
  • Anti-infection Drugs: For combating infections, the company provides drugs such as Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax. These are designed to address a wide range of infections including flu.
  • Healthcare Related Drugs: TTY Biopharm also offers a line of healthcare related drugs like Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin. These products cater to the digest system, osteoporosis, and metabolism, showcasing the company’s dedication to comprehensive health solutions.
  • Functional Foods: Beyond pharmaceuticals, TTY Biopharm is involved in the selling of functional foods. This diversification into food supplements underscores their holistic approach to health and well-being.
  • Import and Export Trading and Investment Activities: The company also engages in import and export trading of its products and investment activities, expanding its footprint in the global market and securing its position as a significant player in the pharmaceutical and healthcare industry.

Contact Information

Address: No.3-1, Park Street
Phone: 886 2 2652 5999